PLEX and corticosteroids show highest clinical response rates in chronic inflammatory demyelinating polyradiculoneuropathy
New FcRn Inhibitors Show Promise for Chronic Inflammatory Neuropathy
This systematic review and network meta-analysis of 2,184 patients evaluated various treatments for chronic inflammatory demyelinating polyr…
Newer treatments like efgartigimod alfa may offer significant clinical responses and improved grip strength for patients with chronic inflam…
JAK inhibitors show 81.7% treatment retention in adult patients with rheumatoid arthritis and interstitial lung disease
New data compares treatments for rheumatoid arthritis and lung disease
This network meta-analysis of 8,186 adult patients with rheumatoid arthritis and interstitial lung disease (RA-ILD) evaluated 14 pharmacolog…
A large review of over 8,000 patients helps identify which medications might best manage both joint pain and lung damage.
IgM-enriched immunoglobulin shows directionally favorable but statistically inconclusive results for short-term mortality in sepsis
IgM Therapy for Sepsis Shows Promise but Not Proof
This meta-analysis of 411 adults with sepsis or septic shock found that IgM-enriched immunoglobulin (Pentaglobin) showed a favorable trend f…
A new analysis hints IgM therapy may lower sepsis deaths, but the evidence isn't strong enough to recommend it yet.
Dipyridamole combined with immunoglobulin and aspirin improves clinical efficacy in children with Kawasaki disease
Dipyridamole Combined with Aspirin Improves Outcomes for Kawasaki Disease
This meta-analysis of randomized controlled trials involving 1,594 children found that adding dipyridamole to immunoglobulin and aspirin sig…
Adding dipyridamole to standard immunoglobulin and aspirin treatment may improve clinical outcomes and speed up recovery for children with K…